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Summary
 
Cells of the dendritic family display some unique properties that confer to them the capacity to
sensitize naive T cells in vitro and in vivo. In the mouse, two subclasses of dendritic cells (DCs)
have been described that differ by their CD8
 
a
 
 expression and their localization in lymphoid
organs. The physiologic function of both cell populations remains obscure. Studies conducted
 
in vitro have suggested that CD8
 
a
 
1
 
 DCs could play a role in the regulation of immune re-
sponses, whereas conventional CD8
 
a
 
2
 
 DCs would be more stimulatory. We report here that
both subclasses of DCs efficiently prime antigen-specific T cells in vivo, and direct the devel-
opment of distinct T helper (Th) populations. Antigen-pulsed CD8
 
a
 
1
 
 and CD8
 
a
 
2
 
 DCs are
separated after overnight culture in recombinant granulocyte/macrophage colony-stimulating
factor and injected into the footpads of syngeneic mice. Administration of CD8
 
a
 
2
 
 DCs in-
duces a Th2-type response, whereas injection of CD8
 
a
 
1
 
 DCs leads to Th1 differentiation. We
further show that interleukin 12 plays a critical role in Th1 development by CD8
 
a
 
1
 
 DCs.
These findings suggest that the nature of the DC that presents the antigen to naive T cells may
dictate the class selection of the adaptative immune response.
Key words: primary response • T helper cell type 1/type 2 balance • interleukin 12 • tolerance • 
memory
 
S
 
ince their discovery 25 years ago, dendritic cells (DCs)
 
1
 
have gained increasing interest from immunologists, as
they are specialized in the capture, processing, and trans-
port of the antigen to lymphoid organs where they proba-
bly sensitize antigen-specific naive T lymphocytes (1).
More recently, Shortman and colleagues developed a pro-
cedure that incorporated a step to dissociate DC–lympho-
cyte complexes, leading to the discovery of a new subset of
DCs that expresses a CD8
 
aa
 
 homodimer and limits the
proliferation of CD4
 
1
 
 T cells in vitro by Fas-mediated
death (2, 3). Based on these observations and on a recent
report that T cell area DCs express high levels of self-pep-
tides (4), it was suggested that the CD8
 
a
 
1
 
 cells could play a
role in peripheral tolerance in vivo, whereas conventional
CD8
 
a
 
2
 
 DCs would initiate immune responses. This hy-
pothesis was challenged by recent reports that IL-12 was
produced by CD8
 
a
 
1
 
 rather than CD8
 
a
 
2
 
 DCs (see below).
This prompted us to assess the function of both subclasses
in vivo by injecting purified DCs, pulsed extracorporeally
with antigen, into the footpads of syngeneic mice and ana-
lyzing the immune response of LN cells.
 
Materials and Methods
 
Mice.
 
Balb/c mice were purchased from Iffa-Credo. Balb/c
IL-12 p40
 
2
 
/
 
2
 
 mice were provided by Dr. J. Magram (Hoffmann-
La Roche, Nutley, NJ [5]). All mice were maintained in our
pathogen-free facility and used at 7–9 wk of age.
 
Purification and Stimulation of DCs.
 
DCs were purified as shown
previously (6), except that spleen cells were digested with colla-
genase, further dissociated in Ca
 
2
 
1
 
-free media in the presence of
EDTA, separated into low- and high-density fractions on a Ny-
codenz gradient, and cultured overnight with 15 ng/ml rmGM-
CSF, as described (3). DCs were pulsed with antigen (30 
 
m
 
g/ml
KLH) during overnight culture (6). The CD8
 
2
 
 or CD8
 
1
 
 status
was maintained after culture in GM-CSF–containing medium for
1–5 d (7; and our unpublished observations), suggesting that
CD8
 
a
 
 is a stable lineage marker. After overnight culture, nonad-
herent cells (containing at least 90% DCs, as assessed by morphol-
ogy and specific staining, using anti-CD11c mAb, N418; refer-
ence 8) were incubated with anti-CD8
 
a
 
–coupled microbeads
 
1
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 DC, dendritic cell. 
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and separated according to CD8
 
a
 
 expression by two passages
over a MACS
 
®
 
 column (Miltenyi Biotec). The CD8
 
a
 
2
 
 DCs
were further enriched by incubation with anti-CD11c–coupled
microbeads and positive selection over a MACS
 
®
 
 column. Alter-
natively, nonadherent cells collected after overnight culture were
separated according to CD8 expression by FACS
 
®
 
 sorting: in
brief, cells were double stained for CD11c expression using
FITC-conjugated N418 and for CD8
 
a
 
 expression using biotin-
conjugated anti-CD8
 
a
 
 mAb (PharMingen) followed by PE-
streptavidin. The cells were gated based on characteristic forward
and side light scatter, and two populations (CD11c
 
1
 
CD8
 
a
 
1
 
 and
CD11c
 
1
 
CD8
 
a
 
2
 
) were sorted on a FACSVantage
 
®
 
 (Becton
Dickinson). The proportion of CD8
 
a
 
1
 
 to CD8
 
a
 
2
 
 DCs at the
end of the purification steps was 10–15% in all experiments per-
formed.
 
Induction of IL-12 from DC Subsets.
 
Low-density spleen cells
(see above) were enriched for CD11c expression and further sep-
arated according to CD8
 
a
 
 expression using a Multisort anti-
FITC kit (Miltenyi Biotech). Cells were cultured overnight with
pansorbin (20 
 
m
 
g/ml; Calbiochem) plus IFN-
 
g
 
 and GM-CSF (20
ng/ml each), and the supernatant was assayed for IL-12 p70 using
ELISA from Genzyme. The detection limit was 8 pg/ml.
 
Immunization Protocol.
 
Antigen-pulsed DCs were washed in
RPMI 1640 and administered at a dose of 3 
 
3
 
 10
 
5
 
 cells into the
hind footpads, according to a protocol described by Inaba et al.
(9). When indicated, some groups of animals were treated with 1 mg
anti-CD4 mAbs (GK 1.5), to selectively deplete CD4
 
1
 
 T cell
subset in vivo, as described previously (10). Some mice were in-
jected daily with 0.2 
 
m
 
g i.p. rmIL-12 on days 0, 1, 2, and 3.
Draining popliteal LNs were harvested 5 d after DC injection.
 
In Vitro Assays.
 
LN cells were cultured in Click’s medium
supplemented with 0.5% heat-inactivated mouse serum and addi-
tives. The proliferation was measured as thymidine incorporation
during the last 16 h of a 4-d culture. Culture supernatants were
assayed for IL-2 after 24–48 h, and for IFN-
 
g
 
, IL-4, IL-5, and IL-10
after 96 h of incubation. IL-2, IFN-
 
g
 
, and IL-10 were measured
as described (11). IL-4 and IL-5 were quantitated by two-site
ELISA from Genzyme and PharMingen, respectively. The detec-
tion limits were 0.05 U/ml for IL-2, 1 ng/ml for IFN-
 
g
 
, 15 pg/ml
for IL-4, 2 U/ml for IL-5, and 0.3 ng/ml for IL-10.
 
Results
 
CD8
 
1
 
 and CD8
 
2
 
 DCs, Pulsed In Vitro with Antigen,
Prime T Cells In Vivo.
 
DCs were purified from spleens,
pulsed with KLH during overnight culture (6), and further
separated according to CD8
 
a
 
 expression by FACS
 
®
 
 sorting
or by positive/negative selection on MACS
 
®
 
. Reanalysis of
the sorted cell populations confirmed purity 
 
.
 
99% (FACS
 
®
 
)
or 97% (MACS
 
®
 
). 3 
 
3
 
 10
 
5
 
 DCs were injected into the
hind footpads of syngeneic mice, and the popliteal LNs
were harvested 5 d later. The data in Fig. 1 a indicate that
administration of purified CD8
 
a
 
1
 
 or CD8
 
a
 
2
 
 DCs, or
both, loaded ex vivo with antigen, resulted in T cell prim-
ing, as assessed by KLH-dependent proliferation in culture.
The proliferative response of LN cells from mice injected
with CD8
 
a
 
1
 
 DCs was consistently higher compared with
animals primed with CD8
 
a
 
2
 
 DCs. T cell priming was pre-
vented by treatment of mice with neutralizing anti-CD4
mAbs, showing that the KLH-specific response was depen-
dent on CD4
 
1
 
 T lymphocytes.
 
The Subclasses of DCs Induce the Development of Distinct Th
Populations.
 
We next analyzed the cytokines (12) released
by LN cells from mice primed with either subset in vivo.
The data in Fig. 1 indicate that the subclasses of DCs have
the potential to differentially skew cytokine production to-
wards Th1 and Th2 tendencies (12): CD8
 
a
 
2
 
 DCs induced
the activation of cells secreting high levels of IL-4, IL-5,
and IL-10 and low levels of IL-2 and IFN-
 
g
 
, whereas
CD8
 
a
 
1
 
 DCs sensitized cells producing IL-2 and IFN-
 
g
 
,
but little IL-4, IL-5, and IL-10. Unseparated splenic DCs
(11; and data not shown) or a combination of both subsets
(at a proportion of 1 CD8
 
a
 
1
 
 to 10 CD8
 
a
 
2
 
) induced the
activation of helper cells secreting a large array of lympho-
kines.
 
Analysis of the Memory Response.
 
These results indicate
that both CD8
 
a
 
1
 
 and CD8
 
a
 
2
 
 subsets of DCs can act as
adjuvant of the immune response and differentially regulate
the development of CD4
 
1
 
 Th cells. As in vitro data sug-
gested that CD8
 
a
 
1
 
 DCs could kill Fas-expressing cells (3),
Figure 1. CD8a1 and CD8a2 DCs prime distinct Th cells in vivo. LN
cells from mice injected with either subset or a combination (at a propor-
tion of 1 CD8a1 to 10 CD8a2) 5 d earlier were cultured without antigen
or with 50 (a) or 10 (a–f) mg/ml KLH. Some mice were injected with 1 mg
anti-CD4 mAbs before priming. Proliferation and lymphokine production
were measured as indicated in Materials and Methods. Figure summarizes
the results (mean 6 SD) obtained in five independent experiments.589 Maldonado-López et al.
T lymphocytes may undergo Fas-mediated apoptosis once
they are activated, i.e., later during the primary response.
Therefore, we tested whether an anamnestic response was
developed. Unseparated, KLH-pulsed DCs were injected
into the hind footpads of mice that were untreated or im-
munized 14 d earlier with various DC populations. LN
cells were harvested 2 d later and cultured with or without
antigen. The data in Fig. 2 a indicate that a memory re-
sponse was induced in all preimmunized groups, as assessed
by antigen-specific T cell proliferation of LN cells from
mice that received two injections of DCs, but not in
groups that received only one injection. Of note, the cy-
tokine profiles were determined by the subclass of DCs
used to prime animals: mice injected with CD8a1 or
CD8a2 DCs and boosted with unseparated DCs displayed
a secondary response of Th1 and Th2 type, respectively
(Fig. 2). These findings indicate that both DC subsets in-
duce the development of memory helper cells that upon
recall with the same antigen differentiate into distinct
helper populations.
Role of IL-12. There is evidence that the maturation of
Th precursors into biased Th1 or Th2 populations is
strongly influenced by cytokines in the environment (13).
In particular, IL-12 appears as the dominant cytokine driv-
ing the differentiation of Th1 lymphocytes in vitro and in
vivo (14, 15). We found that CD8a1 DCs produced high
levels of IL-12 heterodimer upon stimulation, whereas
CD8a2 DCs secreted little if any IL-12 (Table I). The role
of IL-12 in Th1 priming was further documented by the
observation that CD8a1 DCs isolated from mice deficient
for IL-12 (5) induced little IFN-g and intermediate levels
of IL-4 when injected into syngeneic mice, compared with
CD8a1 DCs from wild-type mice (Fig. 3, a and b). Con-
versely, coinjection of rIL-12 and antigen-pulsed CD8a2
DCs resulted in the development of a polarized Th1-type
immune response (Fig. 3, c and d).
Discussion
There is increasing evidence that protection against para-
sites or infectious diseases relies on the character of the im-
mune response, i.e., the Th1/Th2 balance. In particular,
Th1 cells are important effectors involved in the eradica-
tion of intracellular infectious pathogens, whereas Th2
lymphocytes are efficient to eliminate extracellular para-
sites. Importantly, the development of the inappropriate Th
subset not only fails to eradicate the pathogen but can cause
immunopathology (for a review, see reference 13). There-
fore, it is of major interest to identify the factors that influ-
ence the differentiation of distinct Th cell subsets in vivo.
We show herein that two subclasses of DCs differentially
regulate the development of Th cells secreting discrete sets
of lymphokines: CD8a1 DCs direct the differentiation of
Th1 cells, whereas CD8a2 DCs induce Th2-type responses
in vivo. We further show that both DC subclasses induce
memory responses, and that the activation of Th1 responses
by CD8a1 DCs correlates with their production of IL-12
p70 heterodimer.
Figure 2. CD8a1 and CD8a2 DCs induce distinct memory responses
in vivo. Balb/c mice were either left untreated (I) or were primed with
KLH-pulsed CD8a1, CD8a2, or the combination 14 d earlier, and
boosted with unseparated DCs, pulsed with the same antigen. LN cells
were harvested 2 d later and cultured with (a) graded doses or (b–f) 10
mg/ml KLH. Proliferation (a) and lymphokine production (b–f) were
measured as indicated in Materials and Methods. Figure summarizes the
results (mean 6 SD) obtained in four independent experiments.
Table I. Production of IL-12 by DCs
IL-12 p70 (pg/ml)
Untreated
Pansorbin 1 IFN-g 1
GM-CSF
CD8a2 CD8a1 CD8a2 CD8a1
Exp 1 11.5 ,8.0 13.8 190.1
Exp 2 12.7 11.1 33.3 812.2
Exp 3 17.7 19.8 93.3 854.8
Low-density spleen cells were sorted according to CD8a expression
and cultured with or without pansorbin plus IFN-g plus GM-CSF. Su-
pernatants were assayed for IL-12 p70 production 24 h later. Exp, ex-
periment.590 Dendritic Cell Subsets Regulate Th Development
Our data are in agreement with recent reports that
CD8a1 DCs are the source of IL-12. In Flt3 ligand–treated
mice, a DC subset containing a majority of CD8a1 cells
was shown to secrete very high levels of IL-12 (16). Simi-
larly, most DCs exposed to soluble Toxoplasma gondii
tachyzoite extract in vivo that stained for IL-12 p40 were
shown to belong to the CD8a subset (17). In addition, our
results suggest that the same cells, i.e., the transferred DCs,
function as APCs and IL-12–producing cells, as DCs from
p40 knockout mice have lost the capacity to induce a Th1-
type response in a wild-type host. These observations and
other studies suggest that IL-12 is a dominant factor in di-
recting the development of Th1 cells producing high levels
of IFN-g in vitro and in vivo, although other factors may
affect Th subset development (13). Of note, several reports
suggest that IL-12 production by DCs requires their prior
activation and that the amount of IL-12 depends on the
mode of activation. Reis e Sousa and collaborators reported
a CD40L- and IFN-g–independent production of IL-12
after infection with T. gondii or injection of LPS (17). Koch
et al. (18) found that ligation of CD40 and MHC class II
molecules independently triggered IL-12 production by
murine DCs. Similarly, CD40L was found to be the most
effective stimulus to induce IL-12 by DCs generated from
human peripheral blood monocytes (19). Therefore, it is
tempting to speculate that, in our model, the transferred
antigen-pulsed DCs are triggered to release IL-12 upon an-
tigen-specific interaction with T lymphocytes in vivo. Ex-
periments are underway to define the role of CD40–
CD154 interaction in Th1 priming and to compare the
IL-12 produced by DCs at various stages of maturation.
There is some evidence that CD8a1 and CD8a2 DCs
belong to distinct lineages. Shortman and colleagues have
found in intravenous transfer studies that CD8a serves as a
marker of the DC progeny of the low CD4 precursor, in
both the thymus and the spleen of irradiated recipients,
thereby suggesting that CD8a1 DCs are of lymphoid ori-
gin (20, 21). Conversely, the CD8a2 DCs would be of
myeloid origin, as they are relatives of monocytes and mac-
rophages and are GM-CSF dependent (21, 7). Both classes
of DCs maintain their CD8a2 or CD8a1 status in culture
in the presence of GM-CSF, and therefore appear as stable
distinct lineages (7). Of note, CD8a remained a stable
marker on DCs cultured for 5 d in the presence of GM-
CSF, IFN-g, and/or activated T cells (our unpublished ob-
servations).
A recent study by Pulendran et al. (21a) confirmed that
both subsets of DC differentially regulated the develop-
ment of T helper cells in vivo. They showed that the lym-
phoid-related subsets induced high levels of IFN-g and IL-2,
but little Th2 cytokines, whereas the myeloid-related sub-
set induced large amounts of IL-4 and IL-10, in addition to
IFN-g and IL-2. The CD8a1 population used in the
present study is CD11c1CD11bdull  or  2, and therefore is
likely to represent the lymphoid-related population D/E
described by Pulendran and colleagues (16). By contrast,
the CD8a2 DCs are CD11c1CD11b1 and resemble the
myeloid-related DC subset referred to as population C
(data not shown). The distinct regulation of the IFN-g and
IL-2 synthesis, compared with our study, could be related
to differences in the purification procedures, in the matura-
tion state of the DCs transferred (fresh versus cultured
DCs), in the form of antigen (peptide versus protein), and/or
in the precursor frequency of antigen-reactive T cells
(TCR transgenic versus wild-type mice). It is noteworthy
that injection of CD8a1 and CD8a2 DCs isolated from
mice treated with Flt3 ligand (provided by Dr. C. Maliszew-
ski, Immunex, Seattle, WA) induced the development of
similar Th cells compared with DCs purified from un-
treated mice, suggesting that administration of Flt3 ligand
did not alter DC function (data not shown).
Two reports have shown that the cell population con-
taining the highest proportion of CD8a1 cells was consis-
tently less efficient at stimulating the proliferation of anti-
gen-specific cells in vitro (3, 22). A ligand for Fas was
demonstrated on the surface of CD8a1 but not CD8a2
DCs, and the suboptimal activation of T cells by CD8a1
DCs was associated with marked T cell apoptosis via Fas
engagement (3). We show here that injection of pulsed
CD8a1 and CD8a2 DCs induced equally strong T cell
proliferative responses upon in vitro restimulation. Al-
though we did not measure the expansion of T cells in situ,
a difference between the in vitro and in vivo function of
CD8a1 DCs could be due to the segregation of cell popu-
lations into distinct geographic compartments in vivo after
T cell activation (23) compared with the confined mi-
Figure 3. The priming of Th1 cells by CD8a1 DCs is IL-12 depen-
dent. (a and b) CD8a1 or CD8a2 DCs or both subsets, isolated from
p40-deficient (KO) or wild-type (WT) mice, were loaded with KLH and
injected into the footpads of Balb/c mice. (c and d) Balb/c mice were in-
jected in the footpads with CD8a1 or CD8a2 DCs with or without four
daily injections of 200 ng i.p. rmIL-12. LN cells were harvested 5 d later
and cultured with 10 mg/ml antigen. The production of IFN-g and IL-4
was measured in the supernatants, as indicated in Materials and Methods.
Similar data were obtained in all four experiments performed.591 Maldonado-López et al.
croenvironment in culture plates. Alternatively, it is possi-
ble that Th1-type responses, which could be deleterious,
are controlled by a feedback mechanism involving Fas-
mediated killing of T lymphocytes once activated (24, 25). In-
terestingly, there is evidence that CD95L may be a media-
tor of costimulation and inflammation as well as a death
agonist (26–30): CD95L has been shown to recruit neutro-
phils and activate their cytotoxic machinery, leading to lo-
cal inflammation (29). As inflammatory products seem to
induce the maturation of DCs and their migration to lym-
phoid tissues (31, 32), inflammation may be crucial for the
initiation of immunity. Experiments are underway to test
whether FasL expression by CD8a1 is required for the in-
duction of a Th1-type response in vivo.
It is intriguing that CD8a1 and CD8a2 DCs seem to be
located in distinct microenvironments of the spleen (16). In
Balb/c mice, a majority of CD8a2 DCs reside at the mar-
gin between the red and white pulp, whereas most CD8a1
DCs are present in the zones where T cells are located (our
unpublished observations). Injection of LPS results in the
redistribution (32) of both subsets into the T cell area (our
unpublished observations), suggesting that both subsets
have migratory properties. It is notable that CD8a1 DCs
express high levels of DEC-205, a multilectin-like receptor
(33) which could be specific for carbohydrates that are
common constituents of microbial cell walls. In addition,
the expression of CD1d, an MHC-like molecule which
presents antigens mainly derived from prokaryotes (34), has
been shown to be highest on the CD8a1 DC subset (16).
Therefore, it is tempting to speculate that the CD8a1 sub-
set of DCs preferentially capture and present microbial an-
tigens and elicit a Th1-type response.
In conclusion, two subsets of DCs, which differ by phe-
notype, functional, and histologic parameters, exist in the
mouse, each one initiating a different class of response in
vivo and thereby stimulating different effector mechanisms.
Our data show that CD8a1 DCs drive the development of
Th1-type immune responses, whereas CD8a2 DCs induce
the differentiation of Th2-type responses. These observa-
tions predict that CD8a1 DCs might not be exploited to
induce tolerance in vivo and confer immune privilege to
grafts, but instead may be attractive for eliciting therapeutic
antitumor immunity.
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